1,068
Views
0
CrossRef citations to date
0
Altmetric
RESEARCH ARTICLE

Effect of common sedation agents on feline splenic size determined via ultrasonography

ORCID Icon, , ORCID Icon, ORCID Icon, ORCID Icon, & ORCID Icon show all
Pages 244-250 | Received 11 Dec 2022, Accepted 05 Jun 2023, Published online: 28 Jun 2023

Figures & data

Figure 1. Ultrasound images demonstrating position of cursors (connected by solid line) for measurement of splenic thickness. For the head (a) and tail (c) of the spleen, which were imaged in a transverse plane, measurement cursors were placed on the near edge of the parietal capsule margin and the far edge of the visceral capsule margin, adjacent to the indentation from the splenic vein radicle. For the body of the spleen (b), which was imaged in a sagittal plane, the measurement was similarly made from a clearly defined splenic radicle to the opposite surface perpendicular to the long axis of the spleen.

Figure 1. Ultrasound images demonstrating position of cursors (connected by solid line) for measurement of splenic thickness. For the head (a) and tail (c) of the spleen, which were imaged in a transverse plane, measurement cursors were placed on the near edge of the parietal capsule margin and the far edge of the visceral capsule margin, adjacent to the indentation from the splenic vein radicle. For the body of the spleen (b), which was imaged in a sagittal plane, the measurement was similarly made from a clearly defined splenic radicle to the opposite surface perpendicular to the long axis of the spleen.

Table 1. Characteristics of cats (n = 24) included in a study comparing the effect of acepromazine (ACE), alfaxalone (ALF) and dexmedetomidine (DEX), all in combination with morphine, on the size of the spleen measured ultrasonographically.

Figure 2. Mean (SE) thickness of the splenic head (a, transverse plane), body (b, sagittal plane) and tail (c, transverse plane) prior to (T0) and 10 (T10), 20 (T20) and 30 (T30) minutes following IM administration of 0.05 mg/kg acepromazine (ACE), 3 mg/kg alfaxalone (ALF) or 10 μg/kg dexmedetomidine (DEX), each in combination with 0.5 mg/kg morphine in cats (n = 8 per group). Asterisks indicate statistical significance compared to T0: *p < 0.05; **p < 0.01; ***p < 0.001.

Figure 2. Mean (SE) thickness of the splenic head (a, transverse plane), body (b, sagittal plane) and tail (c, transverse plane) prior to (T0) and 10 (T10), 20 (T20) and 30 (T30) minutes following IM administration of 0.05 mg/kg acepromazine (ACE), 3 mg/kg alfaxalone (ALF) or 10 μg/kg dexmedetomidine (DEX), each in combination with 0.5 mg/kg morphine in cats (n = 8 per group). Asterisks indicate statistical significance compared to T0: *p < 0.05; **p < 0.01; ***p < 0.001.

Table 2. Mean (SE) thickness (mm) of the splenic head (transverse plane), body (sagittal plane) and tail (transverse plane) prior to (0 minutes) and 10, 20 and 30 minutes following IM administration of 0.05 mg/kg acepromazine (ACE), 3 mg/kg alfaxalone (ALF) or 10 μg/kg dexmedetomidine (DEX), in combination with 0.5 mg/kg morphine in cats (n = 8 per group).

Figure 3. Mean (± SE) arterial pressure prior to (T0) and 10 (T10), 20 (T20) and 30 (T30) minutes following IM administration of 0.05 mg/kg acepromazine (ACE), 3 mg/kg alfaxalone (ALF) or 10 μg/kg dexmedetomidine (DEX), each in combination with 0.5 mg/kg morphine in cats (n = 8 per group). Statistically significant compared to DEX: *p < 0.05; **p < 0.01; ***p < 0.001.

Figure 3. Mean (± SE) arterial pressure prior to (T0) and 10 (T10), 20 (T20) and 30 (T30) minutes following IM administration of 0.05 mg/kg acepromazine (ACE), 3 mg/kg alfaxalone (ALF) or 10 μg/kg dexmedetomidine (DEX), each in combination with 0.5 mg/kg morphine in cats (n = 8 per group). Statistically significant compared to DEX: *p < 0.05; **p < 0.01; ***p < 0.001.

Table 3. Mean (SE) heart rate (HR), respiratory rate (RR) and temperature, and median (IQR) sedation scores prior to (0 minutes) and 10, 20 and 30 minutes following IM administration of 0.05 mg/kg acepromazine (ACE), 3 mg/kg alfaxalone (ALF) or 10 μg/kg dexmedetomidine (DEX), each in combination with 0.5 mg/kg morphine, in cats (n = 8 per group).